ChemicalBook > Product Catalog > Biochemical Engineering > Nucleoside drugs > Nucleoside Intermediates > 8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE Basic information
- Product Name:
- 8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE
- Synonyms:
-
- 8-BR-CAMP
- 8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE
- 8-BROMOADENOSINE-3',5'-CYCLIC MONOPHOSPHATE
- 8-BROMOADENOSINE-3',5'-CYCLOPHOSPHATE
- 8-BROMOADENOSINE-3',5'-CYCLOPHOSPHORIC ACID
- 8-BROMO-ADENOSINE CYCLIC 3',5'-HYDROGEN PHOSPHATE
- 8-BROMO-CAMP
- 8-BROMOADENOSINE 3' 5'-CYCLIC
- CAS:
- 23583-48-4
- MF:
- C10H11BrN5O6P
- MW:
- 408.1
- EINECS:
- 245-760-6
- Mol File:
- 23583-48-4.mol
More
Less
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE Chemical Properties
- Melting point:
- 254 °C (dec.) (lit.)
- Boiling point:
- 741.9±70.0 °C(Predicted)
- Density
- 2.80±0.1 g/cm3(Predicted)
- storage temp.
- -20°C
- solubility
- aqueous base: soluble
- pka
- 0.95±0.60(Predicted)
- form
- Powder
- color
- Pale Brown
- Sensitive
- Hygroscopic
- BRN
- 591930
MSDS
- Language:English Provider:SigmaAldrich
More
Less
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE Usage And Synthesis
Chemical Properties
White powder
Uses
8-Bromoadenosine 3′,5′-cyclic monophosphate has been used:
- to treat H295R cells as positive controls for CYP19 induction
- as a membrane permeable cAMP analog to study its effect on short-circuit current (Isc)
- to investigate its potential as an inducer of differentiation in Wharton′s jelly-derived mesenchymal stem cells (WJ-MSCs)
Definition
ChEBI: A 3',5'-cyclic purine nucleotide that is 3',5'-cyclic AMP bearing an additional bromo substituent at position 8 on the adenine ring. An activator of cyclic AMP-dependent protein kinase.
Biochem/physiol Actions
8-bromo-adenosine?3′,5′-cyclic?monophosphate?(8-bromo-cAMP), added to hepatocytes during plating helps to increase the acquisition of beta-adrenoceptors.
in vivo
8-Bromo-cAMP (60 mg/kg/day, i.p., 7 days) reduces tumor in CT26 tumor mice[4].
| Animal Model: | CT26 tumor mice[4] |
| Dosage: | 60 mg/kg/day |
| Administration: | i.p., 7 days |
| Result: | Decreases amounts of primary CRC tumor nodules and liver metastases. Reduces vasculogenic mimicry (PAS–CD31 staining of colorectal and intestinal tumors). Inhibits cAMP and VEGF expression, increases expression of PKA in tumor tissues. |
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATESupplier
J & K SCIENTIFIC LTD.
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
Sigma-Aldrich
- Tel
- 021-61415566 800-8193336
- orderCN@merckgroup.com
Shanghai SuperLan Chemcial Technique Centre
- Tel
- 0-2022843681 15618226720
- chaolaichem@foxmail.com
Shenzhen Regent Biochemical Technology Co., Ltd.
- Tel
- 0755-85201366 18938635012
- sales@regentsciences.com
More
Less
8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE(23583-48-4)Related Product Information
- 8-BROMOADENOSINE
- 8-BROMOADENOSINE-3',5'-CYCLIC MONOPHOSPHATE SODIUM SALT HYDRATE
- (7-DIMETHYLAMINOCOUMARIN-4-YL)METHYL-8-BROMOADENOSINE-3',5'-CYCLIC MONOPHOSPHATE, HYDRATE
- 8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE
- 8-BROMOADENOSINE 3':5'-CYCLIC MONOPHOSPHATE SODIUM SALT,8-bromoadenosine 3:5-cyclic*monophosphate sodiu
- BCMCM-CAGED 8-BR-CAMP, 2,5-HYDRATE